Through enhancing the immunogenicity of tumor cells by ICD and promoting the maturation of APCs, thereby initiating CD8+ T‐cell responses, STING activation results in improved therapeutic efficacy.267, 268, 269, 270. Here, CD8A is linked to neoplasm.